[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Over-the-Counter Drug Market Report 2017

August 2017 | 105 pages | ID: U0FB5B87D32EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Over-the-Counter Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Over-the-Counter Drug in these regions, from 2012 to 2022 (forecast).
United States Over-the-Counter Drug market competition by top manufacturers/players, with Over-the-Counter Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bayer HealthCare
  • GSK
  • Johnson & Johnson
  • Pfizer
  • Sanofi
  • Abbott
  • Achelios Therapeutics
  • American Health
  • Amgen
  • AstraZeneca
  • BioGaia
  • Bristol-Myers Squibb
  • Bukwang Pharmaceutica
  • Chr. Hansen
  • Daiichi Sankyo
  • Dr. Reddy's Laboratories
  • Himalaya Drug Company
  • Hypermarcas
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Oral
  • Topical
  • Parenteral
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Over-the-Counter Drug for each application, including
  • Dietary supplements
  • Gastrointestinal drugs
  • Pain medications
  • Respiratory drugs
United States Over-the-Counter Drug Market Report 2017

1 OVER-THE-COUNTER DRUG OVERVIEW

1.1 Product Overview and Scope of Over-the-Counter Drug
1.2 Classification of Over-the-Counter Drug by Product Category
  1.2.1 United States Over-the-Counter Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Over-the-Counter Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Topical
  1.2.5 Parenteral
1.3 United States Over-the-Counter Drug Market by Application/End Users
  1.3.1 United States Over-the-Counter Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Dietary supplements
  1.3.3 Gastrointestinal drugs
  1.3.4 Pain medications
  1.3.5 Respiratory drugs
1.4 United States Over-the-Counter Drug Market by Region
  1.4.1 United States Over-the-Counter Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Over-the-Counter Drug Status and Prospect (2012-2022)
  1.4.3 Southwest Over-the-Counter Drug Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Over-the-Counter Drug Status and Prospect (2012-2022)
  1.4.5 New England Over-the-Counter Drug Status and Prospect (2012-2022)
  1.4.6 The South Over-the-Counter Drug Status and Prospect (2012-2022)
  1.4.7 The Midwest Over-the-Counter Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Over-the-Counter Drug (2012-2022)
  1.5.1 United States Over-the-Counter Drug Sales and Growth Rate (2012-2022)
  1.5.2 United States Over-the-Counter Drug Revenue and Growth Rate (2012-2022)

2 UNITED STATES OVER-THE-COUNTER DRUG MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Over-the-Counter Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Over-the-Counter Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Over-the-Counter Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Over-the-Counter Drug Market Competitive Situation and Trends
  2.4.1 United States Over-the-Counter Drug Market Concentration Rate
  2.4.2 United States Over-the-Counter Drug Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Over-the-Counter Drug Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OVER-THE-COUNTER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Over-the-Counter Drug Sales and Market Share by Region (2012-2017)
3.2 United States Over-the-Counter Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Over-the-Counter Drug Price by Region (2012-2017)

4 UNITED STATES OVER-THE-COUNTER DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Over-the-Counter Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Over-the-Counter Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Over-the-Counter Drug Price by Type (2012-2017)
4.4 United States Over-the-Counter Drug Sales Growth Rate by Type (2012-2017)

5 UNITED STATES OVER-THE-COUNTER DRUG SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Over-the-Counter Drug Sales and Market Share by Application (2012-2017)
5.2 United States Over-the-Counter Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES OVER-THE-COUNTER DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer HealthCare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Over-the-Counter Drug Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer HealthCare Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GSK
  6.2.2 Over-the-Counter Drug Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GSK Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.2 Over-the-Counter Drug Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Over-the-Counter Drug Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Over-the-Counter Drug Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Abbott
  6.6.2 Over-the-Counter Drug Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Abbott Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Achelios Therapeutics
  6.7.2 Over-the-Counter Drug Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Achelios Therapeutics Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 American Health
  6.8.2 Over-the-Counter Drug Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 American Health Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Amgen
  6.9.2 Over-the-Counter Drug Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Amgen Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 AstraZeneca
  6.10.2 Over-the-Counter Drug Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 AstraZeneca Over-the-Counter Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 BioGaia
6.12 Bristol-Myers Squibb
6.13 Bukwang Pharmaceutica
6.14 Chr. Hansen
6.15 Daiichi Sankyo
6.16 Dr. Reddy's Laboratories
6.17 Himalaya Drug Company
6.18 Hypermarcas

7 OVER-THE-COUNTER DRUG MANUFACTURING COST ANALYSIS

7.1 Over-the-Counter Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Over-the-Counter Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Over-the-Counter Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Over-the-Counter Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OVER-THE-COUNTER DRUG MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Over-the-Counter Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Over-the-Counter Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Over-the-Counter Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Over-the-Counter Drug Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Over-the-Counter Drug
Figure United States Over-the-Counter Drug Market Size (K Units) by Type (2012-2022)
Figure United States Over-the-Counter Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Topical Product Picture
Figure Parenteral Product Picture
Figure United States Over-the-Counter Drug Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Over-the-Counter Drug by Application in 2016
Figure Dietary supplements Examples
Figure Gastrointestinal drugs Examples
Figure Pain medications Examples
Figure Respiratory drugs Examples
Figure United States Over-the-Counter Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Over-the-Counter Drug Sales (K Units) and Growth Rate (2012-2022)
Figure United States Over-the-Counter Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Over-the-Counter Drug Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Over-the-Counter Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Over-the-Counter Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Over-the-Counter Drug Sales Share by Players/Suppliers
Figure 2017 United States Over-the-Counter Drug Sales Share by Players/Suppliers
Figure United States Over-the-Counter Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Over-the-Counter Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Over-the-Counter Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Over-the-Counter Drug Revenue Share by Players/Suppliers
Figure 2017 United States Over-the-Counter Drug Revenue Share by Players/Suppliers
Table United States Market Over-the-Counter Drug Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Over-the-Counter Drug Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Over-the-Counter Drug Market Share of Top 3 Players/Suppliers
Figure United States Over-the-Counter Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Over-the-Counter Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Over-the-Counter Drug Product Category
Table United States Over-the-Counter Drug Sales (K Units) by Region (2012-2017)
Table United States Over-the-Counter Drug Sales Share by Region (2012-2017)
Figure United States Over-the-Counter Drug Sales Share by Region (2012-2017)
Figure United States Over-the-Counter Drug Sales Market Share by Region in 2016
Table United States Over-the-Counter Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Over-the-Counter Drug Revenue Share by Region (2012-2017)
Figure United States Over-the-Counter Drug Revenue Market Share by Region (2012-2017)
Figure United States Over-the-Counter Drug Revenue Market Share by Region in 2016
Table United States Over-the-Counter Drug Price (USD/Unit) by Region (2012-2017)
Table United States Over-the-Counter Drug Sales (K Units) by Type (2012-2017)
Table United States Over-the-Counter Drug Sales Share by Type (2012-2017)
Figure United States Over-the-Counter Drug Sales Share by Type (2012-2017)
Figure United States Over-the-Counter Drug Sales Market Share by Type in 2016
Table United States Over-the-Counter Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Over-the-Counter Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Over-the-Counter Drug by Type (2012-2017)
Figure Revenue Market Share of Over-the-Counter Drug by Type in 2016
Table United States Over-the-Counter Drug Price (USD/Unit) by Types (2012-2017)
Figure United States Over-the-Counter Drug Sales Growth Rate by Type (2012-2017)
Table United States Over-the-Counter Drug Sales (K Units) by Application (2012-2017)
Table United States Over-the-Counter Drug Sales Market Share by Application (2012-2017)
Figure United States Over-the-Counter Drug Sales Market Share by Application (2012-2017)
Figure United States Over-the-Counter Drug Sales Market Share by Application in 2016
Table United States Over-the-Counter Drug Sales Growth Rate by Application (2012-2017)
Figure United States Over-the-Counter Drug Sales Growth Rate by Application (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Bayer HealthCare Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table GSK Basic Information List
Table GSK Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure GSK Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure GSK Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Johnson & Johnson Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Pfizer Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Pfizer Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Sanofi Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Sanofi Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Abbott Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Abbott Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table Achelios Therapeutics Basic Information List
Table Achelios Therapeutics Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Achelios Therapeutics Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Achelios Therapeutics Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Achelios Therapeutics Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table American Health Basic Information List
Table American Health Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure American Health Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure American Health Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure American Health Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure Amgen Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure Amgen Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Over-the-Counter Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Over-the-Counter Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Over-the-Counter Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Over-the-Counter Drug Revenue Market Share in United States (2012-2017)
Table BioGaia Basic Information List
Table Bristol-Myers Squibb Basic Information List
Table Bukwang Pharmaceutica Basic Information List
Table Chr. Hansen Basic Information List
Table Daiichi Sankyo Basic Information List
Table Dr. Reddy's Laboratories Basic Information List
Table Himalaya Drug Company Basic Information List
Table Hypermarcas Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Over-the-Counter Drug
Figure Manufacturing Process Analysis of Over-the-Counter Drug
Figure Over-the-Counter Drug Industrial Chain Analysis
Table Raw Materials Sources of Over-the-Counter Drug Major Players/Suppliers in 2016
Table Major Buyers of Over-the-Counter Drug
Table Distributors/Traders List
Figure United States Over-the-Counter Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Over-the-Counter Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Over-the-Counter Drug Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Type in 2022
Table United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Application in 2022
Table United States Over-the-Counter Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Over-the-Counter Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Over-the-Counter Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Over-the-Counter Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications